Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts. more
Time Frame | NURO | Sector | S&P500 |
---|---|---|---|
1-Week Return | 1% | 1.76% | -2.5% |
1-Month Return | 5.3% | 0.33% | -3.91% |
3-Month Return | -1.84% | -8.58% | -0.59% |
6-Month Return | 8.67% | -4.26% | 3.45% |
1-Year Return | 26.1% | 1.27% | 22.31% |
3-Year Return | -89.54% | 5.33% | 25% |
5-Year Return | -86.53% | 38.09% | 77.23% |
10-Year Return | -99.91% | 102.29% | 188.04% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 9.27M | 7.38M | 8.25M | 8.26M | 5.90M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":79.57,"profit":true},{"date":"2021-12-31","value":89.01,"profit":true},{"date":"2022-12-31","value":89.04,"profit":true},{"date":"2023-12-31","value":63.64,"profit":true}] |
Cost of Revenue | 7.03M | 2.13M | 2.33M | 2.51M | 1.95M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":30.29,"profit":true},{"date":"2021-12-31","value":33.18,"profit":true},{"date":"2022-12-31","value":35.66,"profit":true},{"date":"2023-12-31","value":27.81,"profit":true}] |
Gross Profit | 2.25M | 5.25M | 5.92M | 5.75M | 3.95M | [{"date":"2019-12-31","value":37.92,"profit":true},{"date":"2020-12-31","value":88.65,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.11,"profit":true},{"date":"2023-12-31","value":66.66,"profit":true}] |
Gross Margin | 24.22% | 71.15% | 71.75% | 69.65% | 66.89% | [{"date":"2019-12-31","value":33.75,"profit":true},{"date":"2020-12-31","value":99.17,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.07,"profit":true},{"date":"2023-12-31","value":93.23,"profit":true}] |
Operating Expenses | 13.78M | 7.34M | 8.21M | 10.49M | 11.10M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":53.3,"profit":true},{"date":"2021-12-31","value":59.55,"profit":true},{"date":"2022-12-31","value":76.14,"profit":true},{"date":"2023-12-31","value":80.54,"profit":true}] |
Operating Income | (11.53M) | (2.09M) | (2.28M) | (4.74M) | (7.15M) | [{"date":"2019-12-31","value":-1153471100,"profit":false},{"date":"2020-12-31","value":-209490400,"profit":false},{"date":"2021-12-31","value":-228460700,"profit":false},{"date":"2022-12-31","value":-474176600,"profit":false},{"date":"2023-12-31","value":-715152100,"profit":false}] |
Total Non-Operating Income/Expense | - | - | 6.25K | 650.31K | 1.03M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.6,"profit":true},{"date":"2022-12-31","value":62.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (3.77M) | (2.09M) | (2.28M) | (4.42M) | (6.53M) | [{"date":"2019-12-31","value":-377301400,"profit":false},{"date":"2020-12-31","value":-209219500,"profit":false},{"date":"2021-12-31","value":-228150200,"profit":false},{"date":"2022-12-31","value":-441660900,"profit":false},{"date":"2023-12-31","value":-652948700,"profit":false}] |
Income Taxes | (124.01K) | (89.95K) | (76.42K) | (49.39K) | (2.00) | [{"date":"2019-12-31","value":-12401200,"profit":false},{"date":"2020-12-31","value":-8995400,"profit":false},{"date":"2021-12-31","value":-7642300,"profit":false},{"date":"2022-12-31","value":-4939100,"profit":false},{"date":"2023-12-31","value":-200,"profit":false}] |
Income After Taxes | - | - | (2.21M) | (4.37M) | (6.53M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-220507900,"profit":false},{"date":"2022-12-31","value":-436721800,"profit":false},{"date":"2023-12-31","value":-652948500,"profit":false}] |
Income From Continuous Operations | (3.77M) | (2.09M) | (2.28M) | (4.42M) | (5.57M) | [{"date":"2019-12-31","value":-377301400,"profit":false},{"date":"2020-12-31","value":-209219500,"profit":false},{"date":"2021-12-31","value":-228145700,"profit":false},{"date":"2022-12-31","value":-441660900,"profit":false},{"date":"2023-12-31","value":-557181000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (3.65M) | (2.00M) | (2.21M) | (4.37M) | (6.53M) | [{"date":"2019-12-31","value":-364900200,"profit":false},{"date":"2020-12-31","value":-200224100,"profit":false},{"date":"2021-12-31","value":-220507900,"profit":false},{"date":"2022-12-31","value":-436721800,"profit":false},{"date":"2023-12-31","value":-652948700,"profit":false}] |
EPS (Diluted) | (6.60) | (0.89) | (2.41) | (1.61) | (1.68) | [{"date":"2019-12-31","value":-660,"profit":false},{"date":"2020-12-31","value":-89,"profit":false},{"date":"2021-12-31","value":-241,"profit":false},{"date":"2022-12-31","value":-161,"profit":false},{"date":"2023-12-31","value":-168.42,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
NURO | |
---|---|
Cash Ratio | 12.26 |
Current Ratio | 13.88 |
Quick Ratio | 12.70 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
NURO | |
---|---|
ROA (LTM) | -28.21% |
ROE (LTM) | -42.78% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
NURO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.07 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.93 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
NURO | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 2.17 |
P/B | 0.51 |
Price/FCF | NM |
EV/R | 0.24 |
EV/Ebitda | 1.46 |
PEG | NM |
NeuroMetrix Inc (NURO) share price today is $4.01
Yes, Indians can buy shares of NeuroMetrix Inc (NURO) on Vested. To buy NeuroMetrix Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NURO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of NeuroMetrix Inc (NURO) via the Vested app. You can start investing in NeuroMetrix Inc (NURO) with a minimum investment of $1.
You can invest in shares of NeuroMetrix Inc (NURO) via Vested in three simple steps:
The 52-week high price of NeuroMetrix Inc (NURO) is $4.73. The 52-week low price of NeuroMetrix Inc (NURO) is $2.66.
The price-to-earnings (P/E) ratio of NeuroMetrix Inc (NURO) is
The price-to-book (P/B) ratio of NeuroMetrix Inc (NURO) is 0.51
The dividend yield of NeuroMetrix Inc (NURO) is 0.00%
The market capitalization of NeuroMetrix Inc (NURO) is $8.09M
The stock symbol (or ticker) of NeuroMetrix Inc is NURO